SEC Form 4 · accession 0001213900-16-010534
Amarantus Bioscience Holdings, Inc. · AMBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gerald Commissiong
Officer — CEO · Director
Period of report
Feb 1, 2016
Accepted (ET)
Feb 2, 2016 · 10:35 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001424812
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 1, 2016 | J | 45,283 | $0.265 | A | 100,347 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares were issued to Mr. Commissiong in lieu of repayment of certain loans made to the Company ($5k) and in lieu of interest payments made on certain senior secured non-convertible notes paid ($7k) by Mr. Commissiong on behalf of the Company.